Mackenzie Financial Corp Catalent, Inc. Transaction History

Mackenzie Financial Corp

$66.8 Billion
Q3 2024

A detailed history of Mackenzie Financial Corp transactions in Catalent, Inc. stock. As of the latest transaction made, Mackenzie Financial Corp holds 5,968 shares of CTLT stock, worth $363,928. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,968

Previous 5,968 -0.0%

Holding current value

$363,928

Previous $335,000 7.76%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$53.58 - $57.02 $7,018 - $7,469	-131 Reduced 2.15%	5,968 $335,000
Q1 2024 May 10, 2024	BUY	$42.56 - $59.82 $28,855 - $40,557	678 Added 12.51%	6,099 $344,000
Q4 2023 Jan 30, 2024	SELL	$32.18 - $46.57 $38,036 - $55,045	-1,182 Reduced 17.9%	5,421 $243,000
Q3 2023 Oct 25, 2023	BUY	$44.2 - $50.2 $29,481 - $33,483	667 Added 11.24%	6,603 $300,000
Q2 2023 Aug 03, 2023	SELL	$31.86 - $67.26 $276,831 - $584,422	-8,689 Reduced 59.41%	5,936 $257,000
Q1 2023 Apr 24, 2023	SELL	$45.44 - $74.26 $78,565 - $128,395	-1,729 Reduced 10.57%	14,625 $961,000
Q4 2022 Feb 14, 2023	BUY	$41.39 - $81.0 $153,888 - $301,158	3,718 Added 29.42%	16,354 $735,000
Q3 2022 Oct 07, 2022	SELL	$72.36 - $113.1 $28,871 - $45,126	-399 Reduced 3.06%	12,636 $914,000
Q2 2022 Aug 10, 2022	BUY	$87.2 - $114.05 $88,333 - $115,532	1,013 Added 8.43%	13,035 $1.4 Million
Q1 2022 May 13, 2022	BUY	$94.19 - $124.49 $231,707 - $306,245	2,460 Added 25.73%	12,022 $1.33 Million
Q4 2021 Feb 14, 2022	SELL	$119.57 - $139.07 $20,207 - $23,502	-169 Reduced 1.74%	9,562 $1.22 Million
Q3 2021 Nov 08, 2021	BUY	$109.17 - $142.35 $335,042 - $436,872	3,069 Added 46.07%	9,731 $1.3 Million
Q2 2021 Aug 11, 2021	BUY	$100.34 - $115.69 $31,005 - $35,748	309 Added 4.86%	6,662 $720,000
Q1 2021 May 14, 2021	BUY	$101.51 - $125.27 $265,042 - $327,079	2,611 Added 69.78%	6,353 $669,000
Q4 2020 Feb 10, 2021	BUY	$85.88 - $105.36 $4,981 - $6,110	58 Added 1.57%	3,742 $389,000
Q3 2020 Nov 13, 2020	BUY	$72.74 - $92.5 $16,584 - $21,090	228 Added 6.6%	3,684 $316,000
Q2 2020 Aug 13, 2020	BUY	$48.02 - $79.04 $165,957 - $273,162	3,456 New	3,456 $253,000

Others Institutions Holding CTLT

# of Institutions

513

Shares Held

149M

Call Options Held

575K

Put Options Held

2.03M

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mackenzie Financial Corp with notifications on news.

Account

Mackenzie Financial Corp Catalent, Inc. Transaction History